Literature DB >> 7544375

Alloreactive 2C T cells recognize a self peptide in the context of the mutant Kbm3 molecule.

M D Tallquist1, L R Pease.   

Abstract

Previous studies hav shown that 2C T cells have dual specificity for Ld and Kbm3 alloantigens and are positively selected in the context of Kb. Analysis of Kbm3-eluted peptides reveals a single HPLC fraction that is a central component of the Kbm3 allodeterminant. Peptides with biologic and biochemical properties indistinguishable from those of the Kbm3 allopeptide were also isolated from Kb and Kbm8, despite the fact that cells bearing these class I molecules are not efficient targets for 2C T cells. The allopeptide was isolated and compared with p2Ca, the Ld allopeptide recognized by 2C T cells in the context of Ld. The Kbm3 allopeptide was found to be biochemically and functionally different from p2Ca. Therefore, the 2C TCR has dual specificity for two different peptides presented in the context of two structurally distinct class I molecules. The possibility of a common peptide being bound by Kb, Kbm3, and Kbm8 suggests that the peptide defined as an allodeterminant in the context of Kbm3 may also function in the positive selection of 2C T cells when presented in the context of Kb and Kbm8 during thymic development. In support of this view, the allopeptide was also found in Kb and Kbm8 thymic peptide eluates.

Mesh:

Substances:

Year:  1995        PMID: 7544375

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms.

Authors:  Qing Ge; Phillip D Holler; Vinay S Mahajan; Tam Nuygen; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-27       Impact factor: 11.205

2.  Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization.

Authors:  K C Garcia; M D Tallquist; L R Pease; A Brunmark; C A Scott; M Degano; E A Stura; P A Peterson; I A Wilson; L Teyton
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

3.  Breaking tolerance with engineered class I antigen-presenting molecules.

Authors:  Christopher A Parks; Kalli R Henning; Kevin D Pavelko; Michael J Hansen; Virginia P Van Keulen; Brendan K Reed; Jennifer D Stone; Adam G Schrum; Diana Gil; David M Kranz; Andrew J Bordner; Michael A Barry; Larry R Pease
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-06       Impact factor: 11.205

4.  A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity.

Authors:  M D Tallquist; T J Yun; L R Pease
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

5.  Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes.

Authors:  Qibin Leng; Qing Ge; Tam Nguyen; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

6.  H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection.

Authors:  N J Felix; W J Brickey; R Griffiths; J Zhang; L Van Kaer; T Coffman; J P Ting
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

7.  Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.

Authors:  S M O'Herrin; M S Lebowitz; J G Bieler; B K al-Ramadi; U Utz; A L Bothwell; J P Schneck
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.